Stocksigma LogoStocksigma Logo

Cohance Lifesciences Receives MCA Approval for Umang Vohra as Chairman and Group CEO

Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) received Central Government approval from the Ministry of Corporate Affairs on 12th

Cohance Lifesciences Receives MCA Approval for Umang Vohra as Chairman and Group CEO

Cohance Lifesciences Ltd 路 Others (Uncategorized) 路 13 Oct 2026, 1:21 am

Cohance Lifesciences Receives MCA Approval for Umang Vohra as Chairman and Group CEO Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) received Central Government approval from the Ministry of Corporate Affairs on 12th Oct'26 (via letter dated 8th Oct'26) for the appointment of Mr. Umang Vohra as Chairman and Group CEO. This regulatory clearance follows the company's prior intimations dated 27th Apr'26 and 26th Jun'26, formalizing the top leadership transition.

Original exchange filing (PDF)

More announcements from Cohance Lifesciences Ltd

All Cohance Lifesciences Ltd announcements